Relationship between Coronary Artery Disease and Non-HDL-C, and Effect of Highly Purified EPA on the Risk of Coronary Artery Disease in Hypercholesterolemic Patients Treated with Statins: Sub-Analysis of the Japan EPA Lipid Intervention Study (JELIS)
Open accessAbstract
AIM: The present study examined the importance of reducing non-high-density lipoprotein cholesterol (non-HDL-C) for the primary prevention of the occurrence of coronary artery disease (CAD) in the JELIS, and the effects of EPA. METHODS: The patients were distributed into 4 subgroups using the lipid management goal for LDL-C recommended by the Japan Atherosclerosis Society guideline (2007) and the goal for non-HDL-C defined as 30 mg/dL higher than LDL-C: A) achieved both goals; B) achieved the LDL-C but not non-HDL-C goal; C) achieved the non-HDL-C but not LDL-C goal; and D) did not attain either goal. The incidences of CAD in the 4 subgroups were compared, and the effects of eicosapentaenoic acid (EPA) on the risk of CAD in these subgroups were examined. RESULTS: In the non-EPA group, the incidence of CAD in patients who did not achieve the goals for LDL-C or non-HDL-C was higher than in patients who achieved those goals. Patients in subgroups B, C, and D were at higher risk for CAD than those in subgroup A (B, HR 2.31; C, HR 1.90; D, HR 2.47). EPA reduced the risk of CAD by 38% in subgroups B, C, and D (p= 0.007). CONCLUSION: We reconfirmed non-HDL-C as a predictor of the risk for CAD and a residual risk marker of CAD after LDL-C-lowering therapy. EPA was useful to reduce the occurrence of CAD in patients who did not achieve the goals for LDL-C and/or non-HDL-C.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
This is the first dose-response meta-analysis of the relationship between omega-3 PUFA intake and non-HDL-C changes.
“To our best knowledge, this is the first dose–response meta‐analysis of the relationship between ω3 PUFA intake and non‐HDL‐C changes, an indicator of the cholesterol content of all atherogenic lipoproteins. 100 , 150 , 151”
From Association Between Omega-3 Fatty Acid Intake and Dyslipidemia: A Continuous Dose-Response Meta-Analysis of Randomized Controlled Trials (2023) · cites this paper as [150]
Cites
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011 · see citing works
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902 · see citing works
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236 · see citing works
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
Cannon, C. P., Braunwald, E., McCabe, C. H., Rader, D. J., Rouleau, J. L., Belder, R., Joyal, S. V., Hill, K. A., Pfeffer, M. A., & Skene, A. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040583 · Cited by 4,938 · see citing works
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
LaRosa, J. C., Grundy, S. M., Waters, D. D., Shear, C., Barter, P., Fruchart, J.-C., Gotto, A. M., Greten, H., Kastelein, J. J. P., Shepherd, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050461 · Cited by 3,489 · see citing works
Burr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610 · see citing works
Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60527-3 · Cited by 2,516 · see citing works
Self-citationOh, D. Y., Talukdar, S., Bae, E. J., Imamura, T., Morinaga, H., Fan, W., Li, P., Lu, W. J., Watkins, S. M., & Olefsky, J. M. (2010) · Cell · doi:10.1016/j.cell.2010.07.041 · Cited by 2,428 · see citing works
(1999) · PubMed · Cited by 2,062 · see citing works
Fish and Omega-3 Fatty Acid Intake and Risk of Coronary Heart Disease in Women
Hu, F. B. (2002) · JAMA · doi:10.1001/jama.287.14.1815 · Cited by 1,018 · see citing works
Arita, M., Bianchini, F., Aliberti, J., Sher, A., Chiang, N., Hong, S., Yang, R., Petasis, N. A., & Serhan, C. N. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042031 · Cited by 926 · see citing works
Fish consumption and the 30-year risk of fatal myocardial infarction
Daviglus, M. L., Stamler, J., Orencia, A. J., Dyer, A. R., Liu, K., Greenland, P., Walsh, M. K., Morris, D., & Shekelle, R. B. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361502 · Cited by 902 · see citing works
Fatty acid composition of the plasma lipids in Greenland Eskimos
Dyerberg, J., Bang, H., & Hjørne, N. (1975) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/28.9.958 · Cited by 877 · see citing works
Kromann, N., & Green, A. (1980) · PubMed · Cited by 854 · see citing works
Role for Stearoyl-CoA Desaturase-1 in Leptin-Mediated Weight Loss
Cohen, P., Miyazaki, M., Socci, N. D., Hagge-Greenberg, A., Liedtke, W., Soukas, A. A., Sharma, R., Hudgins, L. C., Ntambi, J. M., & Friedman, J. M. (2002) · Science · doi:10.1126/science.1071527 · Cited by 818 · see citing works
The composition of the Eskimo food in north western Greenland.
Bang, H. O., Dyerberg, J., & Sinclair, H. M. (1980) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/33.12.2657 · Cited by 807 · see citing works
Thies, F., Garry, J. M., Yaqoob, P., Rerkasem, K., Williams, J., Shearman, C. P., Gallagher, P. J., Calder, P. C., & Grimble, R. F. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12468-3 · Cited by 739 · see citing works
Kromann, N., & Green, A. (1980) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1980.tb01221.x · Cited by 713 · see citing works
Iso, H., Kobayashi, M., Ishihara, J., Sasaki, S., Okada, K., Kita, Y., Kokubo, Y., & Tsugane, S. (2006) · Circulation · doi:10.1161/circulationaha.105.581355 · Cited by 557 · see citing works
Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment
Kastelein, J. J. P., van der Steeg, W. A., Holme, I., Gaffney, M., Cater, N. B., Barter, P., Deedwania, P., Olsson, A. G., Boekholdt, S. M., Demicco, D. A., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.713438 · Cited by 478 · see citing works
Teramoto, T., Sasaki, J., Ishibashi, S., Birou, S., Daida, H., Dohi, S., Egusa, G., Hiro, T., Hirobe, K., Iida, M., et al. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.15792 · Cited by 468 · see citing works
Self-citationAir Force/Texas Coronary Atherosclerosis Prevention Study
佐々木, 淳. (2008) · Japanese journal of clinical medicine · Cited by 411 · see citing works
Eicosapentaenoic Acid Prevents LPS-Induced TNF-α Expression by Preventing NF-κB Activation
Zhao, Y., Joshi-Barve, S., Barve, S., & Chen, L. H. (2004) · Journal of the American College of Nutrition · doi:10.1080/07315724.2004.10719345 · Cited by 405 · see citing works
Robinson, J. G., Wang, S., Smith, B. J., & Jacobson, T. A. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.10.024 · Cited by 368 · see citing works
Saito, Y., Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.06.003 · Cited by 316 · see citing works
Self-citationLiu, J., Sempos, C. T., Donahue, R. P., Dorn, J., Trevisan, M., & Grundy, S. M. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.06.032 · Cited by 277 · see citing works
Fish consumption and cardiovascular disease in the physicians’ health study: A prospective study
Morris, M. C., Manson, J. E., Rosner, B., Buring, J. E., Willett, W. C., & Hennekens, C. H. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117615 · Cited by 268 · see citing works
Teramoto, T., Sasaki, J., Ueshima, H., Egusa, G., Kinoshita, M., Shimamoto, K., Daida, H., Biro, S., Hirobe, K., Funahashi, T., et al. (2007) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.14.45 · Cited by 265 · see citing works
Self-citationNeschen, S., Morino, K., Dong, J., Wang-Fischer, Y., Cline, G. W., Romanelli, A. J., Rossbacher, J. C., Moore, I. K., Regittnig, W., Muñoz, D. S., et al. (2007) · Diabetes · doi:10.2337/db06-1206 · Cited by 233 · see citing works
Kdo2-Lipid A of Escherichia coli, a defined endotoxin that activates macrophages via TLR-4
Raetz, C. R. H., Garrett, T. A., Reynolds, C. M., Shaw, W. A., Moore, J. D., Smith, D. C., Ribeiro, A. A., Murphy, R. C., Ulevitch, R. J., Fearns, C., et al. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600027-jlr200 · Cited by 222 · see citing works
Antiobesity Effect of Eicosapentaenoic Acid in High-Fat/High-Sucrose Diet–Induced Obesity
Sato, A., Kawano, H., Notsu, T., Ohta, M., Nakakuki, M., Mizuguchi, K., Itoh, M., Suganami, T., & Ogawa, Y. (2010) · Diabetes · doi:10.2337/db09-1554 · Cited by 163 · see citing works
Low-density lipoproteins and risk for coronary artery disease
Ballantyne, C. M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00769-3 · Cited by 145 · see citing works
Eicosapentaenoic Acid Enhances Nitric Oxide Production by Cultured Human Endothelial Cells
Okuda, Y., Kawashima, K., Sawada, T., Tsurumaru, K., Asano, M., Suzuki, S., Soma, M., Nakajima, T., & Yamashita, K. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6328 · Cited by 142 · see citing works
Tagawa, H., Shimokawa, H., Tagawa, T., Kuroiwa‐Matsumoto, M., Hirooka, Y., & Takeshita, A. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199904000-00017 · Cited by 137 · see citing works
Satoh, N., Shimatsu, A., Kotani, K., Sakane, N., Yamada, K., Suganami, T., Kuzuya, H., & Ogawa, Y. (2006) · Diabetes Care · doi:10.2337/dc06-1179 · Cited by 137 · see citing works
Yokoyama, M., & Origasa, H. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00367-3 · Cited by 117 · see citing works
Self-citationHirai, A., Terano, T., Hamazaki, T., Sajiki, J., Kondo, S., Ozawa, A., Fujita, T., Miyamoto, T., Tamura, Y., & Kumagai, A. (1982) · Thrombosis Research · doi:10.1016/0049-3848(82)90112-8 · Cited by 114 · see citing works
Ando, M., Sanaka, T., & Nihei, H. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v10102177 · Cited by 113 · see citing works
Tanabe, N., Iso, H., Okada, K., Nakamura, Y., Harada, A., Ohashi, Y., Ando, T., Ueshima, H., & The Japan Arteriosclerosis Longitudinal Study Group (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0861 · Cited by 99 · see citing works
MacDonald, M. L. E., Singaraja, R. R., Bissada, N., Ruddle, P., Watts, R., Karasinska, J. M., Gibson, W. T., Fiévet, C., Vance, J. E., Staels, B., et al. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700478-jlr200 · Cited by 73 · see citing works
Proposed Guidelines for Hypertriglyceridemia in Japan with Non-HDL Cholesterol as the Second Target
Shimano, H., Arai, H., Harada‐Shiba, M., Ueshima, H., Ohta, T., Yamashita, S., Gotoda, T., Kiyohara, Y., Hayashi, T., Kobayashi, J., et al. (2008) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e560 · Cited by 53 · see citing works
Self-citationFarwell, W. R., Sesso, H. D., Buring, J. E., & Gaziano, J. M. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.06.044 · Cited by 53 · see citing works
Clinical and epidemiological studies of eicosapentaenoic acid (EPA) in Japan
Tamura, Y., Hirai, A., Terano, T., Takenaga, M., Saitoh, H., Tahara, K., & Yoshida, S. (1986) · Progress in Lipid Research · doi:10.1016/0163-7827(86)90092-5 · Cited by 51 · see citing works
The Relationship between Non-HDL Cholesterol and Other Lipid Parameters in Japanese Subjects
Sugimoto, K., Isobe, K., Kawakami, Y., & Yamada, N. (2005) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.12.107 · Cited by 25 · see citing works
Nakamura, N., Hamazaki, T., Kobayashi, M., Ohta, M., & Okuda, K. (1998) · PubMed · Cited by 22 · see citing works
Kawano, H., Yano, T., Mizuguchi, K., Mochizuki, H., & Saitō, Y. (2002) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.9.170 · Cited by 16 · see citing works
Flagged first, then by citations
1 of the 48 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Jacobson, T. A., Ito, M. K., Maki, K. C., Orringer, C. E., Bays, H. E., Jones, P. H., McKenney, J. M., Grundy, S. M., Gill, E. A., Wild, R. A., et al. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.02.003 · Cited by 772 · see citing works
Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook
Raja, V., Aguíar, C., Al-Sayed, N., Chibber, Y. S., ElBadawi, H., Владиславович, Е. М., Hermans, M. P., Pandey, R. C., Ray, K. K., Tokgözoğlu, L. S., et al. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117312 · Cited by 217 · see citing works
Borow, K. M., Nelson, J. R., & Mason, R. P. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.07.035 · Cited by 175 · see citing works
Diagnostic Criteria for Dyslipidemia
Teramoto, T., Sasaki, J., Ishibashi, S., Birou, S., Daida, H., Dohi, S., Egusa, G., Hiro, T., Hirobe, K., Iida, M., et al. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.17152 · Cited by 168 · see citing works
Self-citationPrescription omega-3 fatty acid products containing highly purified eicosapentaenoic acid (EPA)
Brinton, E. A., & Mason, R. P. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0415-8 · Cited by 83 · see citing works
Wang, T., Zhang, X., Zhou, N., Shen, Y., Li, B., Chen, B. E., & Li, X. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.029512 · Cited by 73 · see citing works
Davidson, M. H., Rosenson, R. S., Maki, K. C., Nicholls, S. J., Ballantyne, C. M., Mazzone, T., Carlson, D. M., Williams, L. A., Kelly, M. T., Camp, H. S., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.302926 · Cited by 63 · see citing works
Maki, K. C., Guyton, J. R., Orringer, C. E., Hamilton-Craig, I., Alexander, D. D., & Davidson, M. H. (2016) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2016.03.008 · Cited by 62 · see citing works
Perera, R., McFadden, E. C., McLellan, J., Lung, T. W.-C., Clarke, P., Pérez, T., Fanshawe, T. R., Dalton, A., Farmer, A. A., Glasziou, P., et al. (2015) · Health Technology Assessment · doi:10.3310/hta191000 · Cited by 63 · see citing works
Fish Oil Derived Omega 3 Fatty Acids Suppress Adipose NLRP3 Inflammasome Signaling in Human Obesity
Roberts-Lee, K., Midgette, Y. A., & Shah, R. D. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00220 · Cited by 57 · see citing works
Omega-3 Fatty Acid Blood Levels Clinical Significance Update
Superko, H. R., Superko, A. R., Lundberg, G. P., Margolis, B., Garrett, B. C., Nasir, K., & Agatston, A. S. (2014) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-014-0407-4 · Cited by 55 · see citing works
JCS 2023 Guideline on the Primary Prevention of Coronary Artery Disease
Fujiyoshi, A., Kohsaka, S., Hata, J., Hara, M., Kai, H., Masuda, D., Miyamatsu, N., Nishio, Y., Ogura, M., Sata, M., et al. (2024) · Circulation Journal · doi:10.1253/circj.cj-23-0285 · Cited by 47 · see citing works
Ballantyne, C. M., Braeckman, R. A., Bays, H. E., Kastelein, J. J., Otvos, J. D., Stirtan, W. G., Doyle, R. T., Soni, P. N., & Juliano, R. A. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2014.11.009 · Cited by 46 · see citing works
Omega-3 Fatty Acids, Cognition, and Brain Volume in Older Adults
Loong, S., Barnes, S. R., Gatto, N. M., Chowdhury, S., & Lee, G. J. (2023) · Brain Sciences · doi:10.3390/brainsci13091278 · Cited by 39 · see citing works
Gong, Y., Lin, M., Piao, L., Li, X., Yang, F., Zhang, J., Xiao, B., Zhang, Q., Song, W., Yin, H., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12986 · Cited by 35 · see citing works
Tani, S., Matsuo, R., Imatake, K., Suzuki, Y., Takahashi, A., & Matsumoto, N. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.09.019 · Cited by 35 · see citing works
Omega-3 Fatty Acids in Arterial Hypertension: Is There Any Good News?
Brosolo, G., Porto, A. D., Marcante, S., Picci, A., Capilupi, F., Capilupi, P., Bertin, N., Vivarelli, C., Bulfone, L., Vacca, A., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119520 · Cited by 42 · see citing works
Managing dyslipidemia in patients with Type 2 diabetes
Tomlinson, B., Patil, N. G., Fok, M., & Lam, C. W. K. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1912734 · Cited by 25 · see citing works
Marine-derived n-3 fatty acids therapy for stroke
Campano, C. G. A., MacLeod, M. J., Thiès, F., Aucott, L. S., & Macleod, M. R. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012815 · Cited by 22 · see citing works
Escobar-García, J. D., Prieto, C., Pardo‐Figuerez, M., & Lagaron, J. M. (2021) · Nanomaterials · doi:10.3390/nano11030575 · Cited by 21 · see citing works
Tani, S., Nagao, K., Yagi, T., Atsumi, W., & Hirayama, A. (2016) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-016-0195-y · Cited by 15 · see citing works
Dietary fatty acids and CHD: from specific recommendations to dietary patterns
Delarue, J. (2021) · Nutrition Research Reviews · doi:10.1017/s0954422420000293 · Cited by 13 · see citing works
Tani, S., Nagao, K., Kawauchi, K., Yagi, T., Atsumi, W., Matsuo, R., & Hirayama, A. (2017) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-017-0238-z · Cited by 12 · see citing works
Absolute Risk of Cardiovascular Disease and Lipid Management Targets
Teramoto, T., Sasaki, J., Ishibashi, S., Birou, S., Daida, H., Dohi, S., Egusa, G., Hiro, T., Hirobe, K., Iida, M., et al. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.17392 · Cited by 10 · see citing works
Self-citationNicholls, S. J., & Nelson, A. J. (2020) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000712 · Cited by 8 · see citing works
Marine-derived n-3 fatty acids therapy for stroke
Campano, C. G. A., MacLeod, M. J., Aucott, L. S., & Thiès, F. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012815.pub2 · Cited by 9 · see citing works
Perspectives on a new prescription omega-3 fatty acid, icosapent ethyl, for hypertriglyceridemia
Jacobson, T. A. (2014) · Clinical Lipidology · doi:10.2217/clp.14.10 · Cited by 6 · see citing works
Marine-derived n-3 fatty acids therapy for stroke
Campano, C. G. A., MacLeod, M. J., Aucott, L. S., & Thiès, F. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012815.pub3 · Cited by 6 · see citing works
Wang, K.-L., Wu, C., Wang, K.-F., Chang, C., Chen, L., Lu, T., Lin, S.-J., & Chiang, C. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.24158 · Cited by 5 · see citing works
Yunoki, K., Matsumi, H., Miyoshi, T., Kubo, M., Hata, Y., & Yuasa, S. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12020060 · Cited by 4 · see citing works
The Role of Omega-3 Fatty Acids in Dyslipidemias
Brandt, E. J., & Davidson, M. H. (2015) · Springer eBooks · doi:10.1007/978-3-319-20433-8_5 · Cited by 1 · see citing works
Translating Evidence From Clinical Trials of omega-3 Fatty Acids to Clinical Practice
Nelson, A. J., & Nicholls, S. J. (2020) · Future Cardiology · doi:10.2217/fca-2019-0031 · Cited by 1 · see citing works
Eicosapentaenoic Acid Based Therapies: Fish Facts and Stories
Kuchkuntla, A. R., Patllola, S. H., & Rajjo, T. I. (2021) · Journal of Medicine and HealthCare · doi:10.47363/jmhc/2021(3)161
High-Dose Omega-3 Fatty Acids in Cardiovascular Prevention: Finally Living Up to Their Potential?
Nelson, A. J., Mirzaee, S., & Nicholls, S. J. (2019) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-019-00363-3
Haider, S. S., Shahid, M., Razaq, K., Iqbal, S., Ghafoor, M. T., & Rauf, N. (2021) · The Professional Medical Journal · doi:10.29309/tpmj/2022.29.01.6399
- Authors
- Sasaki, J., Yokoyama, M., Matsuzaki, M., Saito, Y., Origasa, H., Ishikawa, Y., Oikawa, S., Itakura, H., Hishida, H., Kita, T., Kitabatake, A., Nakaya, N., Sakata, T., Shimada, K., Shirato, K., & Matsuzawa, Y.
- Affiliations
- Hyogo Brain and Heart Center (JP)
- Yamaguchi University (JP)
- University of Toyama (JP)
- Kakogawa City Hospital Organization (JP)
- Nippon Medical School (JP)
- Fujita Health University (JP)
- Kobe City Medical Center General Hospital (JP)
- Jichi Medical University (JP)
- Venue
- Journal of Atherosclerosis and Thrombosis
- Publisher
- Japan Atherosclerosis Society
- Published
- 2012
- Volume
- 19
- Issue
- 2
- Pages
- 194-204
- ISSN
- 1340-3478 (ISSN-L)
- 1880-3873
- OpenAlex
- W1964186620
- Cited by
- 35
- References
- 48
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 4 · 2022: 1 · 2021: 5 · 2020: 2 · 2019: 3 · 2018: 1 · 2017: 3 · 2016: 2 · 2015: 4 · 2014: 6 · 2013: 2
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- Locations
- Journal of Atherosclerosis and Thrombosis (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
- Keywords
- coronary artery disease, non-HDL cholesterol, eicosapentaenoic acid, omega-3 fatty acids, hypercholesterolemia, statin therapy, LDL cholesterol, residual cardiovascular risk, primary prevention
- MeSH terms
- Adult, Aged, Coronary Artery Disease, Female, Humans, Hypercholesterolemia, Japan, Cholesterol, HDL, Cholesterol, LDL, Male, Middle Aged, Prospective Studies, Risk Factors, Eicosapentaenoic Acid, Postmenopause, Hydroxymethylglutaryl-CoA Reductase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
